CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. announced today the launch of an updated 2016
direct-to-consumer (DTC) awareness campaign for LINZESS® (linaclotide).
Please see full Prescribing Information including Boxed Warning at http://www.frx.com/pi/linzess_pi.pdf.
The company has made the television advertisement available on
Business Wire's website and YouTube channel. More information about
LINZESS is available at www.linzess.com
and on this YouTube
channel.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160229006663/en/
LINZESS® is a trademark owned by Ironwood Pharmaceuticals, Inc. Any
other trademarks referred to in this alert are the property of their
respective owners. All rights reserved.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160229006663/en/
Ironwood Pharmaceuticals, Inc.
Media Relations:
Trista
Morrison, 617-374-5095
[email protected]
or
Investor
Relations:
Meredith Kaya, 617-374-5082
[email protected]
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media